Cargando…

Ability of the post-operative ALBI grade to predict the outcomes of hepatocellular carcinoma after curative surgery

The albumin-bilirubin (ALBI) grade has been validated as a significant predictor for hepatocellular carcinoma (HCC). However, there is little information about the impact of postoperative ALBI grade in patients with HCC who are undergoing liver resection. We enrolled 525 HCC patients who received pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cho, Wei-Ru, Hung, Chao-Hung, Chen, Chien-Hung, Lin, Chih-Che, Wang, Chih-Chi, Liu, Yueh-Wei, Wu, Yi-Ju, Yong, Chee-Chien, Chen, Kuang-Den, Tsai, Yu-Chieh, Hu, Tsung-Hui, Tsai, Ming-Chao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190718/ https://www.ncbi.nlm.nih.gov/pubmed/32350365 http://dx.doi.org/10.1038/s41598-020-64354-0

Ejemplares similares

Preoperative ALBI grade predicts the outcomes in non-B non-C HCC patients undergoing primary curative resection
por: Tsai, Yu-Chieh, et al.
Publicado: (2021)

Effect of Transarterial Chemoembolization on ALBI Grade in Intermediate-Stage Hepatocellular Carcinoma: Criteria for Unsuitable Cases Selection
por: Chi, Chen-Ta, et al.
Publicado: (2021)

Prognostic Prediction for Patients with Hepatocellular Carcinoma and Ascites: Role of Albumin-Bilirubin (ALBI) Grade and Easy (EZ)-ALBI Grade
por: Liao, Jia-I, et al.
Publicado: (2023)

Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma
por: Yang, Shih-Yu, et al.
Publicado: (2021)

Higher Risk of Tumor Recurrence in NASH-Related Hepatocellular Carcinoma Following Curative Resection
por: Chien, Shih-Chieh, et al.
Publicado: (2022)

Impact of MAFLD on HBV-Related Stage 0/A Hepatocellular Carcinoma after Curative Resection
por: Lin, Yen-Po, et al.
Publicado: (2021)

Predictive Effects of Inflammatory Scores in Patients with BCLC 0-A Hepatocellular Carcinoma after Hepatectomy
por: Huang, Pao-Yuan, et al.
Publicado: (2019)

Living donor liver transplantation for Barcelona clinic liver cancer (BCLC) intermediate-stage hepatocellular carcinoma
por: Tsai, Ming Chao, et al.
Publicado: (2022)

Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade
por: Toyoda, Hidenori, et al.
Publicado: (2016)

Comment on: ‘Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade'
por: Cucchetti, Alessandro, et al.
Publicado: (2016)

Reply to: Comment on: ‘Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade'
por: Johnson, Philip, et al.
Publicado: (2016)

Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
por: Ho, Shu-Yein, et al.
Publicado: (2023)

Concurrent Cholecystectomy Is Associated with a Lower Risk of Recurrence after Curative Resection in Early-Stage Hepatocellular Carcinoma: A 10 Year Observational Single-Center Study
por: Chen, Yu-Syuan, et al.
Publicado: (2021)

The Impact of Direct-Acting Antiviral Therapy on the Risk of Recurrence after Curative Resection in Patients with Hepatitis-C-Virus-Related Early Stage Hepatocellular Carcinoma
por: Chen, Yu-Syuan, et al.
Publicado: (2022)

Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan
por: Tsai, Ming-Chao, et al.
Publicado: (2020)

Short Half-Life of Des-γ-Carboxy Prothrombin Is a Superior Factor for Early Prediction of Outcomes of Hepatocellular Carcinoma Treated with Radiofrequency Ablation
por: Yao, Chih-Chien, et al.
Publicado: (2023)

Preoperative ALBI grade predicts mortality in patients undergoing curative surgery for pancreatic head cancer
por: Azili, Cem, et al.
Publicado: (2023)

Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection
por: Tsai, Ming-Chao, et al.
Publicado: (2019)

BCRP/ABCG2 Inhibition Sensitizes Hepatocellular Carcinoma Cells to Sorafenib
por: Huang, Wei-Chien, et al.
Publicado: (2013)

Real world clinical practice in treating advanced hepatocellular carcinoma: When East meets West
por: Yen, Yi-Hao, et al.
Publicado: (2020)

Functional roles of pluripotency transcription factors in mesenchymal stem cells
por: Tsai, Chih-Chien, et al.
Publicado: (2012)

The Association of Albumin-Bilirubin (ALBI) Grade with Mortality Risk in Trauma Patients with Liver Injuries
por: Chou, Sheng-En, et al.
Publicado: (2023)

Preferred Treatment with Curative Intent for Left Lateral Segment Early Hepatocellular Carcinoma under the Era of Minimal Invasive Surgery
por: Wu, Tsung-Han, et al.
Publicado: (2022)

MicroRNAs in Hepatocellular Carcinoma: Carcinogenesis, Progression, and Therapeutic Target
por: Hung, Chao-Hung, et al.
Publicado: (2014)

Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade
por: Pinato, David J., et al.
Publicado: (2020)

Post-recurrence survival analysis in patients with oligo-recurrence after curative esophagectomy
por: Tsai, Ping-Chung, et al.
Publicado: (2022)

Prognostic value of the ALBI grade among patients with single hepatocellular carcinoma without macrovascular invasion
por: Chen, Wenhao, et al.
Publicado: (2021)

A dorsal CA2 to ventral CA1 circuit contributes to oxytocinergic modulation of long-term social recognition memory
por: Tsai, Tsung-Chih, et al.
Publicado: (2022)

ALBI grade: Evidence for an improved model for liver functional estimation in patients with hepatocellular carcinoma
por: Demirtas, Coskun O., et al.
Publicado: (2021)

Impact of metformin use on the recurrence of hepatocellular carcinoma after initial liver resection in diabetic patients
por: Cho, Wei-Ru, et al.
Publicado: (2021)

Causes of Death among Patients with Hepatocellular Carcinoma According to Chronic Liver Disease Etiology
por: Yen, Yi-Hao, et al.
Publicado: (2023)

Prognosis after resection of single large hepatocellular carcinoma: Results from an Asian high-volume liver surgery center
por: Liu, Yueh-Wei, et al.
Publicado: (2020)

Child Pugh and ALBI grade: past, present or future?
por: Rimini, Margherita, et al.
Publicado: (2020)

Well-Controlled Viremia Predicts the Outcome of Hepatocellular Carcinoma in Chronic Viral Hepatitis Patients Treated with Sorafenib
por: Kuo, Yuan-Hung, et al.
Publicado: (2022)

HBcrAg Predicts Hepatocellular Carcinoma Development in Chronic B Hepatitis Related Liver Cirrhosis Patients Undergoing Long-Term Effective Anti-Viral
por: Chang, Kuo-Chin, et al.
Publicado: (2022)

Decreased succinate dehydrogenase B in human hepatocellular carcinoma accelerates tumor malignancy by inducing the Warburg effect
por: Tseng, Po-Lin, et al.
Publicado: (2018)

Clinical efficacy of 60-mg dexlansoprazole and 40-mg esomeprazole after 24 weeks for the on-demand treatment of gastroesophageal reflux disease grades A and B: a prospective randomized trial
por: Chiang, Hung-Hsien, et al.
Publicado: (2019)

In albis : poemas, 1979-1990 /
por: Magaña, Gabriel, 1944-

The Role of Protease-Activated Receptor 2 in Hepatocellular Carcinoma after Hepatectomy
por: Tsai, Ming-Chao, et al.
Publicado: (2021)

Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinoma
por: Chen, Yen-Hao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1ka2pqeeu136t1q9mkb7mvscpk